Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors

Lignende værker

• Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Impact of tyrosine kinase inhibitors on treatment outcomes
  af: Kebriaei, Partow, et al.
  Udgivet: (2011)
• Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations
  af: Jabbour, Elias, et al.
  Udgivet: (2011)
• Cytogenetics, Donor Type and use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation
  af: Oran, Betul, et al.
  Udgivet: (2014)
• Low-Dose Azacitidine After Allogeneic Stem Cell Transplantation for Acute Leukemia
  af: Jabbour, Elias, et al.
  Udgivet: (2009)
• The First Reported Case of Allogenic Hematopoietic Stem Cell Transplantation for CML Blast Phase (Monocytic Lineage) in the Tyrosine Kinase Inhibitor Era
  af: Shinya Yamada, et al.
  Udgivet: (2022-05-01)